SCHEMBL798561

SCHEMBL798561

Cc1cc(C(=O)O)n(CCOCc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRN P28799 3/20 0.49
SORT1 Q99523 3/20 0.49
KDM5A P29375 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
SRD5A2 P31213 2/20 0.41
SMYD3 Q9H7B4 1/20 0.41
GAA P10253 2/20 0.41
TEAD3 Q99594 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27028490 0.92 GRN (0.47) GRNSORT1KDM5AKDM4CL3MBTL1
SCHEMBL799021 0.88 GAA (0.44) L3MBTL1MAPTTDP1KMT2AMEN1
SCHEMBL25594885 0.84 GRN (0.47) GRNSORT1KMT2AMEN1SRD5A2
SCHEMBL11899889 0.83 GRN (0.73) GRNSORT1MAPTGAAALDH1A1
SCHEMBL28923869 0.83 SMN1; SMN2 (0.46) GRNSORT1MAPTTDP1KMT2A
SCHEMBL20661082 0.82 GRN (0.45) GRNSORT1KMT2AMEN1SRD5A2
SCHEMBL20413736 0.81 POLB (0.46) L3MBTL1MAPTTDP1KMT2AMEN1
SCHEMBL27028458 0.80 SMN1; SMN2 (0.52) L3MBTL1MAPTTDP1KMT2AMEN1
SCHEMBL27028514 0.80 TEAD3 (0.41) GRNSORT1KDM5AKDM4CL3MBTL1
SCHEMBL2518853 0.80 HCAR3 (0.45) GRNSORT1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650371-B2 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity SHIONOGI & CO., LTD. (JP) 2017-05-16 US disclosed
US-20160326158-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY SHIONOGI & CO (JP) 2016-11-10 US disclosed
US-20160108052-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY SHIONOGI & CO (JP) 2016-04-21 US disclosed
US-9273053-B2 Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity SHIONOGI & CO., LTD. (JP) 2016-03-01 US disclosed
US-20150105379-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2015-04-16 US disclosed
US-8637504-B2 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity SHIONOGI & CO., LTD. (JP) 2014-01-28 US disclosed
US-20120071475-A1 UREA DERIVATIVES HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2012-03-22 US disclosed
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 US disclosed
US-20110190279-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108052-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY BACE1, BACE2, APP GRN 80/4885SORT1 913/4885KDM5A 4617/4885
US-20160326158-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY BACE1, BACE2, APP GRN 63/4885SORT1 880/4885KDM5A 4614/4885
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 GRN 4290/4885SORT1 2525/4885KDM5A 1519/4885
US-20150105379-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY BACE1, BACE2, APP GRN 80/4885SORT1 913/4885KDM5A 4617/4885
US-20110190279-A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA SECRETASE INHIBITORY ACTIVITY BACE1, BACE2, APP GRN 80/4885SORT1 913/4885KDM5A 4617/4885
US-20120071475-A1 UREA DERIVATIVES HAVING PI3K-INHIBITING ACTIVITY MTOR, STAT3, SLC14A1 GRN 3446/4885SORT1 2901/4885KDM5A 2898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.